Akari Therapeutics (AKTX) Change in Cash (2014 - 2026)

Akari Therapeutics has disclosed Change in Cash across 9 years of filings, most recently posting -$2.4 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$2.4 million, down 14223.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $186000.0 (down 86.04% YoY), and the FY2025 annual result was $2.6 million, up 319.56% from the prior year.
• Change in Cash came in at -$2.4 million for Q1 2026 at Akari Therapeutics, down from $2.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.9 million in Q2 2024 to a low of -$4.4 million in Q2 2023.
• The 4-year median for Change in Cash is -$886000.0 (2023), against an average of -$801692.3.
• Across the five-year window, Change in Cash soared 558.35% in 2025 and slumped 14223.53% in 2026, its largest moves.
• Akari Therapeutics' Change in Cash stood at -$886000.0 in 2023, then surged by 146.61% to $413000.0 in 2024, then jumped by 558.35% to $2.7 million in 2025, then slumped by 189.55% to -$2.4 million in 2026.
• The last three Change in Cash figures came in at -$2.4 million (Q1 2026), $2.7 million (Q4 2025), and -$227000.0 (Q3 2025), per Business Quant data.